225 related articles for article (PubMed ID: 18304749)
1. Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.
Pistell PJ; Zhu M; Ingram DK
Neuroscience; 2008 Mar; 152(3):594-600. PubMed ID: 18304749
[TBL] [Abstract][Full Text] [Related]
2. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
3. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
4. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
[TBL] [Abstract][Full Text] [Related]
5. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
Puig KL; Kulas JA; Franklin W; Rakoczy SG; Taglialatela G; Brown-Borg HM; Combs CK
Neurobiol Aging; 2016 Apr; 40():22-40. PubMed ID: 26973101
[TBL] [Abstract][Full Text] [Related]
6. Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
Kim TK; Han HE; Kim H; Lee JE; Choi D; Park WJ; Han PL
Exp Mol Med; 2012 Dec; 44(12):740-8. PubMed ID: 23172351
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice.
Hanna A; Horne P; Yager D; Eckman C; Eckman E; Janus C
Genes Brain Behav; 2009 Oct; 8(7):676-84. PubMed ID: 19531156
[TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
9. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.
Aso E; Lomoio S; López-González I; Joda L; Carmona M; Fernández-Yagüe N; Moreno J; Juvés S; Pujol A; Pamplona R; Portero-Otin M; Martín V; Díaz M; Ferrer I
Brain Pathol; 2012 Sep; 22(5):636-53. PubMed ID: 22188425
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
11. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
12. Impaired conditioned taste aversion learning in APP transgenic mice.
Janus C; Welzl H; Hanna A; Lovasic L; Lane N; St George-Hyslop P; Westaway D
Neurobiol Aging; 2004 Oct; 25(9):1213-9. PubMed ID: 15312967
[TBL] [Abstract][Full Text] [Related]
13. Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling.
Chintapaludi SR; Uyar A; Jackson HM; Acklin CJ; Wang X; Sasner M; Carter GW; Howell GR
J Alzheimers Dis; 2020; 73(4):1421-1434. PubMed ID: 31929156
[TBL] [Abstract][Full Text] [Related]
14. Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.
Couch BA; Kerrisk ME; Kaufman AC; Nygaard HB; Strittmatter SM; Koleske AJ
J Comp Neurol; 2013 Apr; 521(6):1395-408. PubMed ID: 23047754
[TBL] [Abstract][Full Text] [Related]
15. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease.
Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091
[TBL] [Abstract][Full Text] [Related]
16. Histological and Behavioral Phenotypes of a Novel Mutated APP Knock-In Mouse.
Plucińska K; Crouch B; Yeap JM; Stoppelkamp S; Riedel G; Platt B
J Alzheimers Dis; 2018; 65(1):165-180. PubMed ID: 30040726
[TBL] [Abstract][Full Text] [Related]
17. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
[TBL] [Abstract][Full Text] [Related]
18. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.
Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM
Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930
[TBL] [Abstract][Full Text] [Related]
20. Telomere length and micronuclei trajectories in APP/PS1 mouse model of Alzheimer's disease: Correlating with cognitive impairment and brain amyloidosis in a sexually dimorphic manner.
Guo X; Li J; Qi Y; Chen J; Jiang M; Zhu L; Liu Z; Wang H; Wang G; Wang X
Aging Cell; 2024 May; 23(5):e14121. PubMed ID: 38450924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]